Director of Developmental and Reproductive Toxicology – DART - Louviers, France - Talented International

Description

In a dynamic and innovative scientific environment, located on the outskirts of Normandy, our customer's site includes a team of nearly 500 professionals dedicated to the discovery and development of new pharmaceutical therapies, while respecting animal welfare.

Your role:

As part of a world-renowned CRO specializing in preclinical studies in reproductive toxicology, you will play a key role as the main contact for customers.

You will manage projects in their entirety, ensuring that they run smoothly from start to finish, working closely with teams of technicians and scientists.

Main Responsibilities:

• Assume the role of Study Director for juvenile, developmental and reproductive toxicity study projects, ensuring compliance with global scientific and regulatory standards.
• Actively participate in meetings with national and international customers, reviewing commercial proposals and providing expert advice on customized study designs.
• Act as the control point for all studies, with overall responsibility for their scientific, technical and regulatory conduct, as well as the interpretation and communication of results.
• Provide specific expertise in areas such as fetal pathology, endocrinology, behavioral toxicity/neurotoxicity and juvenile toxicity.
• Maintain a constant scientific watch to offer specialized guidance to customers, adapting study plans and schedules according to drug development requirements.
  
  

Profile required:

• PHD in Toxicology, Veterinary Doctor or Pharmacy graduate.
• Minimum 10 years' successful experience in the management of reproductive toxicology studies.
• In-depth knowledge of endocrinology, medical or veterinary biology.
• Excellent command of written and spoken English.
• Intermediate Level of French – willing to learn French quickly
• Proven organizational, rigorous and interpersonal skills.
  
  

Contractual benefits :

• Application of the pharmaceutical industry collective agreement.
• Executive contract with French working time reduction (RTT).
• Mutual insurance paid at 100%, company restaurant, CSE (works council).
• Transport and profit-sharing bonuses, occasional remote working possible.
• Workplace not accessible by public transport - Possession of a means of transport essential.
• Site located in Normandy, France
• Possibility of helping with relocation to Normandy
  
  

About the Company:

With a presence in over twenty countries and more than 20,000 employees, our client is recognized worldwide as a benchmark in preclinical research.

Their teams are committed to accelerating the development of new medications through outstanding safety evaluation services. With dedicated staff and state-of-the-art facilities, they offer comprehensive support to their customers, from the design of specialized studies to preclinical development.